Mathematically modelling the spread of hepatitis C in injecting drug users

被引:17
|
作者
Corson, S. [1 ]
Greenhalgh, D. [1 ]
Hutchinson, S. [1 ,2 ]
机构
[1] Univ Strathclyde, Dept Math & Stat, Glasgow G1 1HX, Lanark, Scotland
[2] Hlth Protect Scotland, Glasgow G3 7LN, Lanark, Scotland
基金
英国工程与自然科学研究理事会;
关键词
hepatitis C; injecting drug users; IDUs; HCV elimination; mathematical modelling; HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION; INFECTION; PREVALENCE; IMPACT; REINFECTION; PERSISTENCE; HIV/AIDS; GLASGOW; NEEDLES;
D O I
10.1093/imammb/dqr011
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Mathematical modelling can provide valuable insights into the biological and epidemiological properties of infectious diseases as well as the potential impact of intervention strategies employed by health organizations worldwide. In this paper, we develop a deterministic, compartmental mathematical model to approximate the spread of the hepatitis C virus (HCV) in an injecting drug user (IDU) population. Using analytical techniques, we find that the model behaviour is determined by the basic reproductive number R-0, where R-0 = 1 is a critical threshold separating two different outcomes. If R-0 <= 1 and HCV is initially present in the population, we find that the system will reach a disease-free equilibrium where HCV has been eliminated in all IDUs and needles. If R-0 > 1, then there is a unique positive endemic equilibrium which we show is locally stable. We then use simulations to verify our analytical results and examine the effect of different parameter values and intervention measures on HCV prevalence estimates.
引用
收藏
页码:205 / 230
页数:26
相关论文
共 50 条
  • [31] Cost of treatment in hepatitis C infected injecting drug users.
    Gazdag, G.
    Szabo, O.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2009, 66 (06) : 562 - 562
  • [32] Hepatitis C treatment outcomes for injecting drug users: review of the evidence
    Sacks-Davis, R.
    Gold, J.
    Hellard, M. E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A370 - A370
  • [33] Measuring attitudes toward injecting drug users and people with hepatitis C
    Brener, Loren
    Von Hippel, William
    SUBSTANCE USE & MISUSE, 2008, 43 (3-4) : 295 - 302
  • [34] Hepatitis C reinfection in former and active injecting drug users in Belgium
    Dana Busschots
    Rob Bielen
    Özgür M. Koc
    Leen Heyens
    Rita Verrando
    Chantal de Galocsy
    Christophe Van Steenkiste
    Frederik Nevens
    Håvard Midgard
    Olav Dalgard
    Geert Robaeys
    Harm Reduction Journal, 18
  • [35] Hepatitis C virus genotypes in injecting drug users from Romania
    Sultana, Camelia
    Vagu, Codruta
    Temereanca, Aura
    Grancea, Camelia
    Slobozeanu, Josefina
    Ruta, Simona
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2011, 6 (05): : 672 - 678
  • [36] Hepatitis C virus immunovirology in a social network of injecting drug users
    Hellard, M.
    Aitken, C.
    Bharadwaj, M.
    Bowden, S.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S200 - S201
  • [37] Screening for Hepatitis C in injecting drug users: a cost utility analysis
    Stein, K
    Dalziel, K
    Walker, A
    Jenkins, B
    Round, A
    Royle, P
    JOURNAL OF PUBLIC HEALTH, 2004, 26 (01) : 61 - 71
  • [38] Screening for Hepatitis C in injecting and ex-injecting drug users in North East Essex
    Bishton, E.
    Oluboyede, F.
    Grylls, E.
    Woods, L.
    Thomas, S.
    PUBLIC HEALTH, 2014, 128 (11) : 1036 - 1038
  • [39] Hepatitis B vaccination and injecting drug users
    Carruthers, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A358 - A358
  • [40] An outbreak of hepatitis A amongst injecting drug users
    O'Donovan, D
    Cooke, RPD
    Joce, R
    Eastbury, A
    Waite, J
    Stene-Johansen, K
    EPIDEMIOLOGY AND INFECTION, 2001, 127 (03): : 469 - 473